Five Cheap Healthcare Stocks Poised to Explode
The healthcare sector has witnessed a significant correction in the last 15 months, with many prominent names in the industry losing a noteworthy chunk of their market capitalization in that time.
Achillion Pharmaceuticals Inc (ACHN)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Biotech Movers: Lantheus Holdings Inc (LNTH) and Achillion Pharmaceuticals, Inc. (ACHN)
As we noted last week, the close of the third quarter and the start of the final quarter of the year is when volume really starts to pick up in wider financial asset markets, and there are no markets ...
What Hedge Funds Think About Achillion Pharmaceuticals, Inc. (ACHN)?
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is a $1.09 billion market cap biotech company focused on solutions for infectious diseases.
Five Cheap Healthcare Stocks With Hedge Fund Support
When it comes to the risk-reward ratio, there are very few sectors which can match up to healthcare.
Peter Kolchinsky Is Betting Big On Achillion Pharmaceuticals, Inc. (ACHN), Wave Life Sciences (WVE) & More Heading Into 2016
Peter Kolchinsky founded RA Capital Management in 2001 and focuses mainly on healthcare stocks.
What Do Hedge Funds Think of Achillion Pharmaceuticals, Inc. (ACHN)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
5 Healthcare Stocks Under $10 Ready To Pop
Investing in the healthcare sector can be tricky, especially if you're looking for high returns and want to invest in clinical-stage companies, which represent an above-average risk.
Peter Kolchinsky's New Top Healthcare Pick And Old Favorites
Peter Kolchinsky's RA Capital Management recently filed its 13F with the SEC for the reporting period of June 30. Peter Kolchinsky started RA Capital Management after completing his Ph.D.
Billionaire Steve Cohen Bullish Again (And Now More Than Ever) On Achillion Pharmaceuticals, Inc. (ACHN)
Mere months after closing its previously held stake in the company, Steve Cohen’s Point72 Asset Management appears to be more bullish than ever on Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN).
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
